{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T21:16:17Z","timestamp":1768079777681,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81072465"],"award-info":[{"award-number":["81072465"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571579"],"award-info":[{"award-number":["81571579"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s12026-020-09164-2","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T20:29:47Z","timestamp":1604435387000},"page":"59-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["IL-21 enhances STAT3\/Blimp-1 signaling pathway in B cells and contributes to plasma cell differentiation in newly diagnosed patients with myasthenia gravis"],"prefix":"10.1007","volume":"69","author":[{"given":"Yanan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengzhan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0993-6994","authenticated-orcid":false,"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenghua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deqin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,3]]},"reference":[{"issue":"5","key":"9164_CR1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","volume":"8","author":"MN Meriggioli","year":"2009","unstructured":"Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 2009;8(5):475\u201390.","journal-title":"Lancet Neurol"},{"issue":"10","key":"9164_CR2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14(10):1023\u201336.","journal-title":"Lancet Neurol"},{"issue":"10","key":"9164_CR3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","volume":"2","author":"A Vincent","year":"2002","unstructured":"Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol. 2002;2(10):797\u2013804.","journal-title":"Nat Rev Immunol"},{"issue":"26","key":"9164_CR4","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"NE Gilhus","year":"2016","unstructured":"Gilhus NE. Myasthenia gravis. N Engl J Med. 2016;375(26):2570\u201381.","journal-title":"N Engl J Med"},{"issue":"4","key":"9164_CR5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","volume":"69","author":"JS Tzartos","year":"2012","unstructured":"Tzartos JS. Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis. Archives of Neurology. 2012;69(4):445.","journal-title":"Archives of Neurology"},{"key":"9164_CR6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","volume":"7","author":"W Hoch","year":"2001","unstructured":"Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat.Med. 2001;7:365\u20138.","journal-title":"Nat.Med."},{"key":"9164_CR7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2006.01476.x","volume":"13","author":"GO Skeie","year":"2006","unstructured":"Skeie GO, Apostolski S, Evoli A, Gilhus NE, Hart IK, Harms L, et al. Guidelines for the treatment of autoimmune neuromuscular transmission disorders. Eur JNeurol. 2006;13:691\u20139.","journal-title":"Eur JNeurol"},{"issue":"1","key":"9164_CR8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","volume":"5","author":"NE Gilhus","year":"2019","unstructured":"Gilhus NE, Tzartos S, Evoli A, et al. Myasthenia gravis. Nat. Rev. Dis. Primers. 2019;5(1):30.","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"5","key":"9164_CR9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/WCO.0000000000000596","volume":"31","author":"R Mantegazza","year":"2018","unstructured":"Mantegazza R, Bernasconi P, Cavalcante P. Myasthenia gravis: from autoantibodies to therapy. Curr Opin Neurol. 2018;31(5):517\u201325.","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"9164_CR10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/eji.201847517","volume":"49","author":"J Tellier","year":"2019","unstructured":"Tellier J, Nutt SL. Plasma cells: the programming of an antibody-secreting machine. Eur J Immunol. 2019;49(1):30\u20137.","journal-title":"Eur J Immunol"},{"key":"9164_CR11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nri3795","volume":"15","author":"SL Nutt","year":"2015","unstructured":"Nutt SL, Hodgkin PD, Tarlinton DM, Corcoran LM. The generation of antibody-secreting plasma cells. Nat Rev Immunol. 2015;15:160\u201371.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"9164_CR12","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.4049\/jimmunol.1500725","volume":"197","author":"C-J Zhang","year":"2016","unstructured":"Zhang C-J, Gong Y, Zhu W, Qi Y, Yang C-S, Fu Y, et al. Augmentation of circulating follicular helper T cells and their impact on autoreactive B cells in myasthenia gravis. J Immunol. 2016;197(7):2610\u20137.","journal-title":"J Immunol"},{"key":"9164_CR13","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1007\/s12026-016-8872-0","volume":"64","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Zhang X, Xia Y, Jia X, Li H, Zhang Y, et al. CD19+ Tim-1+ B cells are decreased and negatively correlated with disease severity in myasthenia gravis patients. Immunol Res. 2016;64:1216\u201324.","journal-title":"Immunol Res"},{"key":"9164_CR14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/bs.ai.2016.03.001","volume":"131","author":"YH Yu","year":"2016","unstructured":"Yu YH, Lin KI. Factors that regulate the generation of antibody-secreting plasma cells. Adv Immunol. 2016;131:61\u201399.","journal-title":"Adv Immunol"},{"key":"9164_CR15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.coi.2007.01.003","volume":"19","author":"A Kallies","year":"2007","unstructured":"Kallies A, Nutt SL. Terminal differentiation of lymphocytes depends on Blimp-1. Curr Opin Immunol. 2007;19:156\u201362.","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"9164_CR16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ni.3349","volume":"17","author":"M Minnich","year":"2016","unstructured":"Minnich M, Tagoh H, Bnelt P, et al. Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation. Nat Immunol. 2016;17(3):331\u201343.","journal-title":"Nat Immunol"},{"key":"9164_CR17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1074-7613(03)00267-X","volume":"19","author":"M Shapiro-Shelef","year":"2003","unstructured":"Shapiro-Shelef M, Lin KI, McHeyzer-Williams LJ, et al. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity. 2003;19:607\u201320.","journal-title":"Immunity."},{"key":"9164_CR18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1084\/jem.20091777","volume":"207","author":"D Zotos","year":"2010","unstructured":"Zotos D, Coquet JM, Zhang Y, et al. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J Exp Med. 2010;207:365\u201378.","journal-title":"J Exp Med"},{"key":"9164_CR19","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.4049\/jimmunol.179.12.8180","volume":"179","author":"VL Bryant","year":"2007","unstructured":"Bryant VL, Ma CS, Avery DT, Li Y, Good KL, Corcoran LM, et al. Cytokine- mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J Immunol. 2007;179:8180\u201390.","journal-title":"J Immunol"},{"key":"9164_CR20","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.4049\/jimmunol.1102786","volume":"188","author":"B Rodriguez-Bayona","year":"2012","unstructured":"Rodriguez-Bayona B, Ramos-Amaya A, Bernal J, et al. Cutting edge: IL-21 derived from human follicular helper T cells acts as a survival factor for secondary lymphoid organ, but not for bone marrow, plasma cells. J Immunol. 2012;188:1578\u201381.","journal-title":"J Immunol"},{"issue":"9","key":"9164_CR21","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.4049\/jimmunol.179.9.5886","volume":"179","author":"S Kuchen","year":"2007","unstructured":"Kuchen S, Robbins R, Sims GP, Sheng C, Phillips TM, Lipsky PE, et al. Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J Immunol. 2007;179(9):5886\u201396.","journal-title":"J Immunol"},{"key":"9164_CR22","doi-asserted-by":"crossref","first-page":"667","DOI":"10.4049\/jimmunol.0903207","volume":"186","author":"AL Rankin","year":"2011","unstructured":"Rankin AL, MacLeod H, Keegan S, Andreyeva T, Lowe L, Bloom L, et al. IL-21 receptor is critical for the development of memory B cell responses. J Immunol. 2011;186:667\u201374.","journal-title":"J Immunol"},{"key":"9164_CR23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.20091738","volume":"207","author":"MA Linterman","year":"2010","unstructured":"Linterman MA, Beaton L, Yu D, et al. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J.Exp. Med. 2010;207:353\u201363.","journal-title":"J.Exp. Med."},{"key":"9164_CR24","doi-asserted-by":"crossref","unstructured":"Nicholas A Barnes, Sophie Stephenson, Mario Cocco, et al. BLIMP-1 and STAT3 counterregulate microRNA-21 during plasma cell differentiation. J Immunol 2012; 189(1):253\u2013260.","DOI":"10.4049\/jimmunol.1101563"},{"issue":"4","key":"9164_CR25","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.4049\/jimmunol.1201678","volume":"190","author":"BB Ding","year":"2013","unstructured":"Ding BB, Bi E, Chen H, Yu JJ, Ye BH. IL-21 and CD40L synergistically promote plasma cell differentiation through upregulation of Blimp-1 in human B cells. J Immunol. 2013;190(4):1827\u201336.","journal-title":"J Immunol"},{"issue":"7","key":"9164_CR26","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.4049\/jimmunol.180.7.4805","volume":"180","author":"SA Diehl","year":"2008","unstructured":"Diehl SA, Schmidlin H, Nagasawa M, et al. STAT3-mediated up-regulation of BLIMP1 is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J Immunol. 2008;180(7):4805\u201315.","journal-title":"J Immunol"},{"key":"9164_CR27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.humimm.2012.11.019","volume":"74","author":"Z Zhou","year":"2013","unstructured":"Zhou Z, Li A, Wang Z, Pei F, Xia Q, Liu G, et al. Blimp-1 siRNA inhibits B cell differentiation and prevents the development of lupus in mice. Hum Immunol. 2013;74:297\u2013301.","journal-title":"Hum Immunol"},{"key":"9164_CR28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/08916934.2014.976627","volume":"48","author":"J Luo","year":"2015","unstructured":"Luo J, Niu X, Zhang M, Zhang K, Chen M, Deng S. Inhibition of B lymphocyte-induced maturation protein-1 reduces the production of autoantibody and alleviates symptoms of systemic lupus erythematosus. Autoimmunity. 2015;48:80\u20136.","journal-title":"Autoimmunity."},{"key":"9164_CR29","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/ng.472","volume":"41","author":"JW Han","year":"2009","unstructured":"Han JW, Zheng HF, Cui Y, Sun LD, Ye DQ, Hu Z, et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet. Nov. 2009;41:1234\u20137.","journal-title":"Nat Genet"},{"key":"9164_CR30","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/ng.468","volume":"41","author":"V Gateva","year":"2009","unstructured":"Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, Sun X, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet. 2009;41:1228\u201333.","journal-title":"Nat Genet"},{"key":"9164_CR31","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.4049\/jimmunol.1600218","volume":"198","author":"Z Bank\u00f3","year":"2017","unstructured":"Bank\u00f3 Z, Pozsgay J, Szili D, T\u00f3th M, G\u00e1ti T, Nagy G, et al. Induction and differentiation of IL-10-producing regulatory B cells from healthy blood donors and rheumatoid arthritis patients. J Immunol. 2017;198:1512\u201320.","journal-title":"J Immunol"},{"key":"9164_CR32","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2119\/molmed.2014.00231","volume":"20","author":"SJ Kim","year":"2015","unstructured":"Kim SJ, Goldstein J, Dorso K, Merad M, Mayer L, Crawford JM, et al. Expression of Blimp-1 in dendritic cells modulates the innate inflammatory response in dextran sodium sulfate-induced colitis. Mol Med. 2015;20:707\u201319.","journal-title":"Mol Med"},{"key":"9164_CR33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jneuroim.2018.10.007","volume":"325","author":"SI Aqel","year":"2018","unstructured":"Aqel SI, Granitto MC, Nuro-Gyina PK, Pei W, Liu Y, Lovett-Racke AE, et al. Distinct roles for Blimp-1 in autoreactive CD4 T cells during priming and effector phase of autoimmune encephalomyelitis. J Neuroimmunol. 2018;325:20\u20138.","journal-title":"J Neuroimmunol"},{"key":"9164_CR34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00125-012-2722-y","volume":"56","author":"MH Lin","year":"2013","unstructured":"Lin MH, Chou FC, Yeh LT, Fu SH, Chiou HYC, Lin KI, et al. B lymphocyte-induced maturation protein 1 (BLIMP-1) attenuates autoimmune diabetes in NOD mice by suppressing Th1 and Th17 cells. Diabetologia. 2013;56:136\u201346.","journal-title":"Diabetologia."},{"key":"9164_CR35","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jaci.2018.06.046","volume":"143","author":"L Benevides","year":"2019","unstructured":"Benevides L, Costa RS, Tavares LA, Russo M, Martins GA, da Silva LLP, et al. B lymphocyte-induced maturation protein 1 controls TH9 cell development, IL-9 production, and allergic inflammation. J Allergy Clin Immunol. 2019;143:1119\u201330.","journal-title":"J Allergy Clin Immunol"},{"key":"9164_CR36","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","volume":"330","author":"DB Drachman","year":"1994","unstructured":"Drachman DB. Medical progress: myasthenia gravis. N Engl J Med. 1994;330:1797\u2013810.","journal-title":"N Engl J Med"},{"key":"9164_CR37","first-page":"16","volume":"55","author":"A Jaretzki","year":"2000","unstructured":"Jaretzki A, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. 2000;55:16\u201323.","journal-title":"Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America"},{"key":"9164_CR38","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3389\/fimmu.2017.00913","volume":"8","author":"A Swadhinya","year":"2017","unstructured":"Swadhinya A, Nos\u00e9 Brent D, Gauthaman S, et al. Intrinsic plasma cell differentiation defects in B cell expansion with NF-\u03baB and T cell anergy patient B cells. Front Immunol. 2017;8:913.","journal-title":"Front Immunol"},{"issue":"246","key":"9164_CR39","doi-asserted-by":"crossref","first-page":"246ra99","DOI":"10.1126\/scitranslmed.3009131","volume":"6","author":"XN Wu","year":"2014","unstructured":"Wu XN, Ye YX, Niu JW, et al. Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus. ence Translational Medicine. 2014;6(246):246ra99.","journal-title":"ence Translational Medicine"},{"key":"9164_CR40","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","volume":"353","author":"T Rhen","year":"2005","unstructured":"Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids\u2013new mechanisms for old drugs. N Engl J Med. 2005;353:1711\u201323.","journal-title":"N Engl J Med"},{"key":"9164_CR41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12929-017-0354-8","volume":"24","author":"SH Fu","year":"2017","unstructured":"Fu SH, Yeh LT, Chu CC, Yen BLJ, Sytwu HK. New insights into Blimp-1 in T lymphocytes: a divergent regulator of cell destiny and effector function. J Biomed Sci. 2017;24:49.","journal-title":"J Biomed Sci"},{"key":"9164_CR42","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1749-6632.1993.tb22890.x","volume":"681","author":"S Ragheb","year":"1993","unstructured":"Ragheb S, Lisak RP. Phenotypic and functional abnormalities of B cells in myasthenia gravis. Ann N Y Acad Sci. 1993;681:256\u201363.","journal-title":"Ann N Y Acad Sci"},{"key":"9164_CR43","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.4049\/jimmunol.1601415","volume":"198","author":"JA Vander Heiden","year":"2017","unstructured":"Vander Heiden JA, Stathopoulos P, Zhou JQ, Chen L, Gilbert TJ, Bolen CR, et al. Dysregulation of B cell repertoire formation in myasthenia gravis patients revealed through deep sequencing. J Immunol. 2017;198:1460\u201373.","journal-title":"J Immunol"},{"key":"9164_CR44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jneuroim.2018.07.006","volume":"323","author":"M Hocao\u011flu","year":"2018","unstructured":"Hocao\u011flu M, Durmu\u015f H, \u00d6zkan B, Yent\u00fcr SP, Do\u011fan \u00d6, Parman Y, et al. Increased costimulatory molecule expression of thymic and peripheral B cells and a sensitivity to IL-21 in myasthenia gravis. J Neuroimmunol. 2018;323:36\u201342.","journal-title":"J Neuroimmunol"},{"key":"9164_CR45","first-page":"65","volume":"5","author":"ML Tangye","year":"2014","unstructured":"Tangye ML. SG2 cytokine-mediated regulation of plasma cell generation: IL-21 takes center stage. Front Immunol. 2014;5:65.","journal-title":"Front Immunol."},{"key":"9164_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2019.01.013","volume":"99","author":"D Long","year":"2019","unstructured":"Long D, Chen Y, Wu H, Zhao M, Lu Q. Clinical significance and immunobiology of IL-21 in autoimmunity. J Autoimmun. 2019;99:1\u201314.","journal-title":"J Autoimmun"},{"key":"9164_CR47","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.4049\/jimmunol.177.8.5236","volume":"177","author":"KL Good","year":"2006","unstructured":"Good KL, Bryant VL, Tangye SG. Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21. J Immunol. 2006;177:5236\u201347.","journal-title":"J Immunol"},{"key":"9164_CR48","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/35105066","volume":"1","author":"WJ Leonard","year":"2001","unstructured":"Leonard WJ. Cytokines and immunodeficiency diseases. Nat Rev Immunol. 2001;1:200\u20138.","journal-title":"Nat Rev Immunol"},{"key":"9164_CR49","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.4049\/jimmunol.180.7.4805","volume":"180","author":"SA Diehl","year":"2008","unstructured":"Diehl SA, Schmidlin H, Nagasawa M, van Haren SD, Kwakkenbos MJ, Yasuda E, et al. STAT3-mediated up-regulation of BLIMP1 is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J Immunol. 2008;180:4805\u201315.","journal-title":"J Immunol"},{"key":"9164_CR50","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.immuni.2009.10.008","volume":"31","author":"H Kwon","year":"2009","unstructured":"Kwon H, Thierry-Mieg D, Thierry-Mieg J, Kim H-P, Oh J, Tunyaplin C, et al. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity. 2009;31:941\u201352.","journal-title":"Immunity"},{"key":"9164_CR51","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1038\/onc.2011.79","volume":"30","author":"UM Fagerli","year":"2011","unstructured":"Fagerli UM, Ullrich K, St\u00fchmer T, Holien T, K\u00f6chert K, Holt RU, et al. Serum\/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells. Oncogene. 2011;30:3198\u2013206.","journal-title":"Oncogene."},{"key":"9164_CR52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10072-013-1460-3","volume":"35","author":"Y Li","year":"2014","unstructured":"Li Y, Rauniyar VK, Yin WF, Hu B, Ouyang S, Xiao B, et al. IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis. Neurol Sci. 2014;35:29\u201334.","journal-title":"Neurol Sci"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-020-09164-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-020-09164-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-020-09164-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T13:37:05Z","timestamp":1614692225000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-020-09164-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,3]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["9164"],"URL":"https:\/\/doi.org\/10.1007\/s12026-020-09164-2","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,3]]},"assertion":[{"value":"14 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Ethics Committee of Affiliated Hospital of Xuzhou Medical University approved the study protocol.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}